Literature DB >> 1969575

Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus.

E Hartter, T Svoboda, B Lell, M Schuller, B Ludvik, W Woloszczuk, R Prager.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1969575     DOI： 10.1016/0140-6736(90)90966-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

2.  Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.

Authors:  E Hartter; T Svoboda; B Ludvik; M Schuller; B Lell; E Kuenburg; M Brunnbauer; W Woloszczuk; R Prager
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Authors:  A Kautzky-Willer; K Thomaseth; G Pacini; M Clodi; B Ludvik; C Streli; W Waldhäusl; R Prager
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

4.  Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans.

Authors:  B Ludvik; M Clodi; A Kautzky-Willer; M Capek; E Hartter; G Pacini; R Prager
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

Review 5.  The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell.

Authors:  Olivia McCarthy; Signe Schmidt; Merete Bechmann Christensen; Stephen C Bain; Kirsten Nørgaard; Richard Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.